PO-0987: Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells. - Waissi, W.; Burckel, H.; Magisson, E.; Larderet, G.; Noel, G. (Radiotherapy & Oncology, 2017)